Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People expected to live more than 10 more years
- People with suspected prostate cancer that has not spread beyond the prostate gland
- People whose physical prostate examination (a test where a doctor checks the prostate by touch) shows a suspicious finding at a stage called cT2
- People whose PSA blood test result (a marker related to prostate health) is between 3 and 20 ng/ml
Who may not be able to join:
- People whose physical prostate examination suggests the cancer may have grown beyond the prostate (stages cT3 or cT4)
- People with a PSA blood test result above 20 ng/ml
- People who have already been diagnosed with prostate cancer
- People for whom an MRI scan or a prostate biopsy (tissue sample) would not be safe or suitable (confirm with trial site)
- People taking medications that are known to affect PSA blood test results
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Petter Davik, MD, PhD, Norwegian University of Science and Technology (NTNU)
Phone: +47 72829919
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection of clinically significant prostate cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.